CARLOS ROLDAN to Neoplasms
This is a "connection" page, showing publications CARLOS ROLDAN has written about Neoplasms.
Connection Strength
0.590
-
Methylene blue for intractable pain from oral mucositis related to cancer treatment: a randomized phase 2 clinical trial. BMC Med. 2022 11 03; 20(1):377.
Score: 0.133
-
Non-Invasive Pelvic Floor Rehabilitation in Cancer Population: An Incomplete Cohort. Pain Physician. 2022 10; 25(7):E1115-E1120.
Score: 0.133
-
Sacroiliac joint pain following iliac-bone marrow aspiration and biopsy: a cohort study. Pain Manag. 2019 May; 9(3):251-258.
Score: 0.105
-
Oral pain associated with cancer therapy, a pain medicine perspective. Pain Manag. 2018 Nov 01; 8(6):487-493.
Score: 0.101
-
Sympathetic Blockade for Pain Associated With Nonaxial Bone Lesions in Patients With Cancer: An Uncontrolled Cohort. J Natl Compr Canc Netw. 2024 10; 22(8):537-542.
Score: 0.038
-
Subanesthetic ketamine in the ambulatory setting for refractory cancer pain: a 6-year retrospective at a cancer center. Pain Manag. 2021 May; 11(3):267-276.
Score: 0.030
-
Sacroiliitis in cancer patients: a review of current literature. Pain Manag. 2020 Mar; 10(2):107-115.
Score: 0.028
-
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Modulate the Function of Myelinated Fibers after Chemotherapy: A Quantitative Sensory Testing Study. Pain Physician. 2017 05; 20(4):281-292.
Score: 0.023